Third Circuit Affirms Dismissal of Complaint, Finding Investors Failed to Sufficiently Allege Amarin's Statements Were False or Misleading | Goodwin
On June 14, 2022, the U.S. Court of Appeals for the Third Circuit affirmed the dismissal of a securities suit brought by investors in pharmaceutical company, Amarin Corporation, PLC,...